In addition to the previously mentioned ABC transporters ABCB1, ABCG2, and ABCC1, ABCC10 expression may be considered as a predictive biomarker for MDR in non-small cell lung cancer treatment following treatment with paclitaxel [6]. Here, ABCC1 is linked to non-small cell lung carcinoma.